India’s Dr. Reddy’s Labs announced a pact to assist with clinical trials for Russia’s Sputnik V coronavirus vaccine and to get 100 million doses of the vaccine; RDY stock rose to a buy zone.

The post India Pharma Inks Supply, Clinical Trials Pact For Russia's Sputnik Coronavirus Vaccine appeared first on Investor's Business Daily.